Biotechs and Pharmaceuticals
6.5 million adults in the U.S. and the five major European countries have advanced NASH, and puts thepeak market for medicines at $35 billion to $40 billion.
@adamfeuerstein Jan 14th BLUE Webcasting #JPM15 Breakout Session / post.Adam Feuerstein
Juno has partnered with world leading medical and research organizations to advance a broad pipelineofnovel immunotherapies, including the Fred Hutchinson Cancer Research Center, or FHCRC, the Mmorial Sloan Kettering Cancer Center, or MSK, and the Seattle Children’s Research Institute, or SCRI
Analysts Rating Network
1/29/2015 Oppenheimer Outperform $375.00 View Tweet This Rating Share This Rating on StockTwits
1/15/2015 Cowen and Company Set Price Target Buy $420.00 View Tweet This Rating Share This Ratigon StockTwits1/7/2015
Summer Street Set Price Target Buy $650.00 View Tweet This Rating Share This
NASH, puts the peak market for medicines at $35 billion to $40 billion
Hot stocks security
now with today news will announce
Adage Capital Partners Healthcare Fund Bought 20% Of Their Portfolio is ADXS Posted
Adage Capital Partners Healthcare Fund Bought Over $4 Million Shares ADXS cont...
ADAGE CAPITAL PARTNERS GP LLC ..... SC 13G, Advaxis Inc, ADXS, 2015-1-29, 2014-12-15,4,454,604, 0, new position.
Investor Business Daily
Mutual Funds Are Buying Up This Cybersecurity Stock
BY ALISSA WILLIAMS, INVESTOR'S BUSINESS DAILY
Its high Accumulation/Distribution Rating can be attributed, in part, to its strong industry group, with top-rated CyberArk Software